Document is current

Article History

First Online: 5 August 2023

Disclosures

: E.A.M. reports compensated service on scientific advisory boards for Astra Zeneca, BioNTech, and Merck; uncompensated service on steering committees for Bristol Myers Squibb and Roche/Genentech; institutional research support from Roche/Genentech (via SU2C grant) and Gilead; research funding from Susan Komen for the Cure, for which she serves as a Scientific Advisor; and uncompensated participation as a member of the American Society of Clinical Oncology Board of Directors. T.A.K. reports speaker honoraria and an advisory board role for Exact Sciences and is on the global advisory board of Besins Healthcare. All other authors report no disclosures.